通过优化可溶性较差的黄醇的生物可用性,通过基于专辑蛋白的纳米颗粒扩大治疗潜力
Shayeri Chatterjee Ganguly1, Ritam Maity1, Priya Manna1
1Department of Pharmaceutical Technology, Brainware University, Kolkata, India.
Drug development and industrial pharmacy
|April 5, 2025
概括
基于白蛋白的纳米颗粒 (ABNP) 提高了水溶性较差的黄醇的可溶性和生物可用性. 本综述详细介绍了使用ABNP最大限度地提供黄醇的策略,解决配方和药理动力学优势.
科学领域:
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 黄醇具有显著的治疗潜力,但由于水溶性差和生物可用性低而受到限制.
- 低溶解度,透性和化学不稳定性阻碍了黄类药物作为药物的临床应用.
研究的目的:
- 提供一个全面的概述,以提高水溶性较差的黄醇的生物可用性,使用基于白蛋白的纳米颗粒 (ABNPs) 的策略.
- 批判性地评估ABNP介导的黄醇输送的药理动力学优势,物理化学性质和配方原理.
主要方法:
- 审查现有关于新型药物输送方法的文献对黄类药物.
- 专注于基于白蛋白的纳米材料作为提高溶解性和生物可用性的有效载体.
- 评估ABNP配方策略,包括表面修改,交叉连接和结合.
主要成果:
- 与其他聚合物纳米载体相比,基于专的纳米材料在增强黄类溶解性和生物可用性方面表现出卓越的有效性.
- 由于其多功能表面修饰能力,ABNP在药物捕获和加载方面具有优势.
- ABNP表现出生物降解性和生物相容性,这对于有效的药物输送系统至关重要.
结论:
- 基于白蛋白的纳米颗粒是一种高效的方法,可以克服黄醇的生物可用性限制.
- 需要进一步的研究来规范ABNP配方程序,并阐明flavonols和albumin之间的机制相互作用.
- 严格的体内有效性测试对于充分验证ABNP产生的黄醇的治疗潜力至关重要.
相关概念视频
01:23Factors Influencing Bioavailability: First-Pass Elimination
6.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.0K
01:13Bioavailability: Overview
2.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.6K
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
164
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
164
01:29Drug Distribution: Plasma Protein Binding
4.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.7K
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
110
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
110
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
660
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
660